Clinical Trial Update: Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of Vorinostat with radiation therapy and 5-FU for locally advanced pancreatic adenocarcinoma; the study was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Pancreas
• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Vorinostat (vorinostat)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer, Adenocarcinoma of the Pancreas | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-10